Compare MVST & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MVST | KRMD |
|---|---|---|
| Founded | 2006 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 848.0M | 288.6M |
| IPO Year | N/A | N/A |
| Metric | MVST | KRMD |
|---|---|---|
| Price | $2.78 | $6.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $6.00 | $5.88 |
| AVG Volume (30 Days) | ★ 4.3M | 194.4K |
| Earning Date | 11-10-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $444,504,000.00 | $39,070,637.00 |
| Revenue This Year | $24.19 | $23.36 |
| Revenue Next Year | $17.70 | $18.63 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 19.82 | ★ 22.12 |
| 52 Week Low | $1.09 | $1.86 |
| 52 Week High | $7.12 | $6.61 |
| Indicator | MVST | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 32.41 | 60.91 |
| Support Level | $3.28 | $5.48 |
| Resistance Level | $3.16 | $6.61 |
| Average True Range (ATR) | 0.17 | 0.32 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 0.00 | 53.94 |
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extends from core battery chemistry to battery packs.
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).